Lactuflor

Lactulose, the active ingredient in Lactuflor, is an osmotic laxative presented as an oral preparation for oral use. It works by increasing the osmotic pressure within the intestinal lumen, drawing water into the bowel and acidifying colonic contents, which helps to promote bowel movements and to trap ammonia for excretion in patients with liver disease. GNH USA supplies Lactuflor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product meets European Union quality standards and is distributed under strict regulatory oversight.

Lactulose is an osmotic laxative used to treat conditions related to bowel motility and hepatic ammonia accumulation.

Constipation: softens stools, increases water content in the colon, and enhances peristalsis to relieve chronic constipation and improve stool frequency. Hepatic encephalopathy: lowers systemic ammonia by converting it to ammonium in the colon, thereby improving mental status and reducing neurological symptoms in patients with liver disease. Prevention of hepatic encephalopathy recurrence: maintains low colonic ammonia production, helping to prevent future episodes of encephalopathy in chronic liver disease management.

Lactulose may cause a range of adverse reactions, most of which are related to its osmotic activity in the gut.

Common Side Effects: - Bloating: sensation of abdominal fullness that may be uncomfortable. - Diarrhea: loose, watery stools that can lead to dehydration if severe. - Nausea: feeling of sickness that may be accompanied by an urge to vomit. - Flatulence: increased intestinal gas causing bloating or discomfort. - Abdominal cramps: intermittent pain in the abdomen that may be crampy.

Serious or Rare Side Effects: - Electrolyte imbalance: significant changes in potassium or sodium that can affect heart rhythm. - Severe dehydration: marked loss of body fluids that may require medical attention. - Allergic reaction: rash, itching, or swelling that may indicate hypersensitivity. - Hypernatremia: elevated blood sodium concentration that can cause neurologic symptoms. - Hepatic decompensation: worsening liver function in susceptible patients that may precipitate encephalopathy.

When prescribing lactulose, several precautions should be observed to ensure safe and effective use.

Dose titration: start with the lowest effective dose and adjust based on clinical response. Fluid intake: maintain adequate hydration to reduce risk of dehydration. Monitor electrolytes: check serum potassium and sodium regularly in long‑term therapy. Diabetes caution: monitor blood glucose as lactulose may affect glycemic control. Pediatric use: adjust dosing carefully in children and monitor growth parameters. Store at ambient temperature: keep in the original container, protect from moisture and heat.

Lactulose can interact with other medicines, altering their effectiveness or increasing adverse effects.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: may reduce lactulose efficacy by binding in the gut. - Metronidazole: concurrent use may increase the risk of gastrointestinal side effects.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate electrolyte disturbances when combined with lactulose‑induced diarrhea. - Insulin or oral hypoglycemics: lactulose can affect blood glucose levels, requiring closer monitoring. - Antibiotics altering gut flora: may change lactulose metabolism and its ammonia‑lowering effect. - Proton pump inhibitors: may reduce gastric acidity, potentially altering lactulose breakdown.